Opioid Prescription After Cesarean Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

5,521

Participants

Timeline

Start Date

September 21, 2020

Primary Completion Date

April 7, 2022

Study Completion Date

July 8, 2022

Conditions
Pregnancy RelatedOpioid UsePain
Interventions
DRUG

0 to 20 tablets of oxycodone 5mg

Individualized opioid prescription protocol (IOPP) that includes shared decision making

DRUG

Fixed opioid prescription

20 tablets of oxycodone 5mg

Trial Locations (12)

10032

Columbia University, New York

15213

Magee Womens Hospital of UPMC, Pittsburgh

17599

University of North Carolina-Chapel Hill, Chapel Hill

19104

Hospital of the University of Pennsylvania, Philadelphia

35233

University of Alabama - Birmingham, Birmingham

43210

Ohio State University, Columbus

44109

Case Western Reserve-Metrohealth, Cleveland

60611

Northwestern University, Chicago

77030

University of Texas - Houston, Houston

77555

University of Texas Medical Branch, Galveston

84132

University of Utah Medical Center, Salt Lake City

02905

Brown Univeristy, Providence

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

The George Washington University Biostatistics Center

OTHER

NCT04296396 - Opioid Prescription After Cesarean Trial | Biotech Hunter | Biotech Hunter